Abstract
Purpose
Contrast-induced encephalopathy (CIE) was defined as new onset of neurological deficits after exposure to contrast media, which could be observed after the endovascular treatment for intracranial aneurysms.
Methods
We enrolled a consecutive cohort of patients who underwent endovascular treatment for unruptured intracranial aneurysms. CIE was defined as a reversible neuropathic syndrome that occurred after interventional therapy, accompanied by imaging abnormalities and excluding other diseases. Multivariable Poisson regression analysis was performed to show risk factors by incidence rate ratio (IRR) and a clinical strategy was proposed.
Results
Among the 579 patients who underwent interventional therapy for intracranial aneurysms, the crude incidence rate of CIE was 2.4% (95% CI, 1.2–3.6%) at our center. Headache, hemiplegia, and disorientation could be initial symptoms, and cortical blindness was the most common localized deficit. Cerebral edema and sulci effacement on CT were observed, and re-revaluation after treatments on CT/MRI showed absent lesions. The risk factors were history of stroke (IRR, 7.752; P = 0.007), history of hypertension (IRR, 1.064; P = 0.042), posterior circulation aneurysms (IRR, 9.412; P = 0.004) and higher dosage of contrast agents (IRR, 1.018; P = 0.007). After the strategy of accelerating excretion of contrast agents, reduction of intracranial pressure and anti-inflammation/vasospasm therapy, the prognosis was favorable with most patients fully recovered within 72 h.
Conclusion
History of stroke and posterior circulation aneurysms were main risk factors for CIE. A higher dosage of contrast agents might induce CIE, and the history of hypertension should be considered as well.
Similar content being viewed by others
References
Deb-Chatterji M, Schäfer L, Grzyska U, Gelderblom M (2018) Stroke-mimics: an acute brainstem syndrome after intravenous contrast medium application as a rare cause of contrast-induced neurotoxicity. Clin Neurol Neurosurg 174:244–246
Chu YT, Lee KP, Chen CH et al (2020) Contrast-induced encephalopathy after endovascular thrombectomy for acute ischemic stroke. Stroke 51(12):3756–3759
Meijer FJA, Steens SCA, Tuladhar AM et al (2022) Contrast-induced encephalopathy- neuroimaging findings and clinical relevance. Neuroradiology 64(6):1265–1268
Quintas-Neves M, Araújo JM, Xavier SA, Amorim JM, Silva CE, V, Pinho J, (2020) Contrast-induced neurotoxicity related to neurological endovascular procedures: a systematic review. Acta Neurol Belg 120(6):1419–1424
Silverman SM, Bergman PS, Bender MB (1961) The dynamics of transient cerebral blindness: report of nine episodes following vertebral angiography. Arch Neurol 4(3):333–348
Kamimura T, Nakamori M, Imamura E et al (2021) Low-dose contrast-induced encephalopathy during diagnostic cerebral angiography. Intern Med 60(4):629–633
Liu MR, Jiang H, Li XL, Yang P (2020) Case report and literature review on low-osmolar, non-ionic iodine-based contrast-induced encephalopathy. Clin Interv Aging 15:2277–2289
García-Pérez D, Parra-Serrano J, Panero I, Moreno LM, Campollo J, Alén JF (2021) Transient cortical blindness secondary to contrast-induced encephalopathy following diagnostic cerebral angiography: report of 2 cases. Acta Neurol Belg 121(2):585–589
Vigano’ M, Mantero V, Basilico P et al (2021) Contrast-induced encephalopathy mimicking total anterior circulation stroke: a case report and review of the literature. Neurol Sci 42(3):1145–1150
Zevallos CB, Dandapat S, Ansari S et al (2020) Clinical and imaging features of contrast-induced neurotoxicity after neurointerventional surgery. World Neurosurg 142:e316–e324
Li W, Zhu W, Sun X et al (2021) Retreatment with flow diverters and coiling for recurrent aneurysms after initial endovascular treatment: a propensity score-matched comparative analysis. Front Neurol 12:625652
Yao LD, Zhu XL, Yang RL, Zhang MM (2021) Cardiorespiratory arrest after iso-osmolar iodinated contrast injection: a case report of contrast-induced encephalopathy following contrast-enhanced computed-tomography. Medicine (Baltimore) 100(2):e24035
Leong S, Fanning NF (2012) Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. A case report and review of the literature. Interv Neuroradiol. 18(1):33–41
Bender M, Bogdan G, Radančević D, Pejanović-Škobić N (2020) Contrast-induced encephalopathy following cerebral angiography in a hemodialysis patient. Case Rep Neurol Med 2020:3985231
Rebeles F, Fink J, Anzai Y et al (2006) Blood-brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging 17(2):107–116
Avsenik J, Bisdas S, Popovic KS (2015) Blood-brain barrier permeability imaging using perfusion computed tomography. Radiol Oncol 49(2):107–114
de Falco A, De Simone M, d’Onofrio F, Spitaleri D, de Falco FA (2019) Posterior reversible encephalopathy syndrome overlapping contrast-induced encephalopathy after coronary angiography. Neurol Sci 40(9):1951–1953
Zhang G, Wang H, Zhao L et al (2020) Contrast-induced encephalopathy resulting from use of ioversol and iopromide. Clin Neuropharmacol 43(1):15–19
Donepudi B, Trottier S (2018) A seizure and hemiplegia following contrast exposure: understanding contrast-induced encephalopathy. Case Rep Med 2018:9278526
Şimşek EÇ, Ertürk E, Uçar R et al (2019) Transient contrast neurotoxicity after percutaneous coronary intervention mimicking subarachnoid hemorrhage in a patient with chronic kidney disease. Clin Med Insights Case Rep 12:1179547619867671
Fernando TG, Nandasiri S, Mendis S et al (2020) Contrast-induced encephalopathy: a complication of coronary angiography. Pract Neurol 20(6):482–485
Harada Y, Kairamkonda SR, Ilyas U et al (2020) Pearls & Oy-sters: contrast-induced encephalopathy following coronary angiography: a rare stroke mimic. Neurology 94(23):e2491–e2494
Yang Z, Li R, Yue J, Wei Y, Zhang X, Yin R (2019) Fatal contrast medium-induced adverse response to iohexol in carotid artery angioplasty: a case report. Medicine (Baltimore) 98(33):e16758
Zhao W, Zhang J, Song Y et al (2019) Irreversible fatal contrast-induced encephalopathy: a case report. BMC Neurol 19(1):46
Shahid I, Lancelot E, Desché P (2020) Future of diagnostic computed tomography: an update on physicochemical properties, safety, and development of X-ray contrast media. Invest Radiol 55(9):598–600
Cha MJ, Kim SM, Ahn TR, Choe YH (2020) Comparing feasibility of low-tube-voltage protocol with low-iodine-concentration contrast and high-tube-voltage protocol with high-iodine-concentration contrast in coronary computed tomography angiography. PLoS ONE 15(7):e0236108
Du X, Lu B, Hu D, Song B, Li K (2019) An open label, prospective, multicenter, non-interventional study of iodixanol 270 mg I/mL for use in individuals undergoing computed tomography angiography in real-world clinical practice. Acta Radiol 60(2):177–185
Matsubara N, Izumi T, Miyachi S, Ota K, Wakabayashi T (2017) Contrast-induced encephalopathy following embolization of intracranial aneurysms in hemodialysis patients. Neurol Med Chir (Tokyo) 57(12):641–648
Pokersnik JA, Liu L, Simon EL (2018) Contrast-induced encephalopathy presenting as acute subarachnoid hemorrhage. Am J Emerg Med 36(6):1122.e3-1122.e4
McMahon D, Oakden W, Hynynen K (2020) Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure. Theranostics 10(4):1604–1618
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The study protocol was approved by the ethics committee of Beijing Tiantan Hospital, and the approval number given by the ethical board was KY 2018–098-02.
Informed consent
Participants gave informed consent to participate in the study before taking part.
Conflict of interest
We declare that we have no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, M., Liu, J., Chen, F. et al. Contrast-induced encephalopathy following endovascular treatment for intracranial aneurysms—risk factors analysis and clinical strategy. Neuroradiology 65, 629–635 (2023). https://doi.org/10.1007/s00234-022-03077-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-022-03077-7